The mRNA vaccines were released globally in early 2021 with the slogan 'safe and effective'. Unusually for a new class of medicine, they were soon recommended by public health authorities for pregnant women. By late 2021, working age women, including those who were pregnant, were being thrown out of employment for not agreeing to be injected. Those who took the mRNA vaccines did so based on trust in health authorities – the assumption being that they would not have been approved if the evidence was not absolutely clear. The role of regulatory agencies was to protect the public and, therefore, if they were approved, the drugs were safe.

Recently, a lengthy vaccine evaluation report sponsored by Pfizer and submitted to the Australian regulator, the Therapeutic Goods Administration (TGA) dated January 2021 was released under a Freedom of Information request. The report contains significant new information that had been supressed by the TGA and by Pfizer itself. Much of this relates directly to the issues of safety in pregnancy and impacts on the fertility of women of child-bearing age. The whole report is important, but four key data points stand out:

The rapid decline in antibody and T cells in monkeys following a second dose;

Biodistribution studies (previously released in 2021 through an FOI request in Japan);

Data on the impact of fertility outcomes for rats;

Data on foetal abnormalities in rats.